Atlas Trials

The Impact on Hepatic Recurrence After Adjuvant Chemotherapy With Intraarterial Infusion of Idarubicin-Lipiodol

Clinical trial NCT04178642 · WITHDRAWN

Trial details

NCT number
NCT04178642
Sponsor
University Hospital, Montpellier
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2020-09-22
Primary completion
2021-07-14
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.